Sleep apnea syndrome and heart failure—mechanisms and consequences
نویسندگان
چکیده
منابع مشابه
Sleep obstructive apnea syndrome consequences.
Many paleontologists believe that between 200 and 300 thousand years ago, human ancestors started to suffer their most important anatomical change: the transformation of the upper airways. Such change included facial shortening, foramen magnus anteriorization, angle reduction between the horizontal and vertical portions of the upper airway, and especially larynx descending. This new configurati...
متن کامل[Sleep apnea-hypopnea syndrome and the heart].
Cardiovascular and cerebrovascular diseases are the most common diseases in industrialized societies. The main objectives of this article were to summarize the physiological effects of sleep apnea on the circulatory system and to review how treatment of this condition influences cardiovascular disease. Acute sleep apnea has a number of hemodynamic consequences, such as pulmonary and systemic hy...
متن کاملSleep apnea and heart failure: Part II: central sleep apnea.
In the first part of this 2-part review, we provided a synopsis of the cardiovascular effects of normal sleep and an overview of the diagnostic, pathophysiological, and therapeutic implications of obstructive sleep apnea (OSA) in the setting of heart failure (HF). In this second part, we turn our attention to central sleep apnea (CSA), commonly referred to as Cheyne-Stokes respiration. This bre...
متن کاملSleep apnea and heart failure: Part I: obstructive sleep apnea.
Heart failure (HF) affects 5 to 6 million North Americans and is increasing in prevalence.1 Mortality remains high. In Ontario, for example, between 1994 and 1997, approximately 33% of patients diagnosed with HF on first admission to hospital died within 1 year.2 Reductions in mortality demonstrated in randomized clinical trials of pharmacological agents, such as -receptor blockers3 and angiote...
متن کاملSleep Apnea and Heart Failure
Heart failure (HF) affects 5 to 6 million North Americans and is increasing in prevalence.1 Mortality remains high. In Ontario, for example, between 1994 and 1997, approximately 33% of patients diagnosed with HF on first admission to hospital died within 1 year.2 Reductions in mortality demonstrated in randomized clinical trials of pharmacological agents, such as -receptor blockers3 and angiote...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pneumologia
سال: 2019
ISSN: 2247-059X
DOI: 10.2478/pneum-2019-0017